Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q2 Net Loss Narrows To SEK 8.9 Mln

July 13 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * Q2 NET SALES AMOUNTED TO SEK 59.3 MILLION (30.4)
    * Q2 NET SALES IN BUSINESS AREA THORACIC AMOUNTED TO SEK
49.9
MILLION (30.3) AND ABDOMINAL SEK 9.4 MILLION
    * Q2 ADJUSTED OPERATING PROFIT BEFORE DEPRECIATION AND
AMORTIZATION (EBITDA) AMOUNTED TO SEK 8.4 MILLION (-1.0)
    * Q2 NET PROFIT AMOUNTED TO SEK -8.9 MILLION (-16.0)
    * Q2 ADJUSTED OPERATING PROFIT (EBIT) AMOUNTED TO SEK 0.6
MILLION
(-8.2)

Source text for Eikon:  ID:nMFN5FB2HS 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Xvivo Perfusion AB

See all news